|
Genotype frequencies for single markers used in both direct and indirect association analysis obtained with the Haploview 3.2 software package. P-values and OR are for allelic analysis. |
||||||||
| Exon/Intron |
Nucleotide change |
Chromosome location |
Amino acid change |
Genotypes Cases 11/12/22 |
Controls 11/12/22 |
MAF Cases/controls |
Allele 1 vs. allele 2 p-value |
OR (95% CI) |
|
|
||||||||
| 1 |
g.IVS1-70G>A |
121 754 613 |
---- |
165/115/19 |
206/176/24 |
0.26/0.28 |
0.43 |
0.90 [0.71–1.15] |
| 4 |
T131>C |
121 786 462 |
Val44Ala |
296/1/0 |
405/0/0 |
0.0/0.0 |
0.42 |
ND |
| 4 |
C636>T |
121 786 967 |
Pro212Pro |
296/1/0 |
405/0/0 |
0.0/0.0 |
0.42 |
ND |
| 5 |
g.IVS4-26G>A |
121 788 920 |
---- |
153/115/32 |
97/181/34 |
0.30/0.30 |
0.91 |
0.98 [0.78–1.24] |
| 5 |
C1134>T |
121 789 001 |
Leu378Leu |
295/2/0 |
404/1/0 |
0.0/0.0 |
0.58 |
2.73 [0.36–20.9] |
| 6 |
g.IVS5+188A>C |
121 789 313 |
---- |
133/118/42 |
173/181/53 |
0.34/0.35 |
0.78 |
0.97 [0.77–1.21] |
| 6 |
g.IVS5+235A>G |
121 789 360 |
---- |
151/115/33 |
196/183/32 |
0.30/0.30 |
0.95 |
1.01 [0.80–1.27] |
| 7 |
g.IVS6-62G>A |
121 804 161 |
---- |
291/6/0 |
397/8/0 |
0.01/0.01 |
1.00 |
1.02 [0.37–2.84] |
| 7 |
g.IVS6-23T>C |
121 804 200 |
---- |
154/118/27 |
202/179/31 |
0.29/0.29 |
0.86 |
0.98 [0.76–1.23] |
| 10 |
C1861>T |
121 814 302 |
Arg621Cys |
293/4/0† |
395/10/0 |
0.01/0.01 |
0.42 |
0.54 [0.18–1.64] |
| 10 |
G2125>C |
121 814 565 |
Glu709Gln |
296/1/0 |
401/4/0 |
0.0/0.0 |
0.40 |
0.34 [0.05–2.27] |
|
†One PSP affected (not accounted for here) was found to be homozygous for this variant. OR-Odds ratio. The SNPs used for indirect analysis were highly heterozygous; rs1946649, g.IVS1-70G>A (ObsHet; 0.41); rs2242224, g.IVS4-26G>A (ObsHet; 0.42); rs304383, g.IVS5+188A>C (ObsHet; 0.43); rs2242223, g.IVS5+235A>G (ObsHet; 0.42) and rs22900987, g.IVS6-23T>C (0.42). | ||||||||
Myhre et al. BMC Medical Genetics 2008 9:19 doi:10.1186/1471-2350-9-19 |
||||||||